Investigators involved in a multicenter study co-led by Cedars-Sinai discovered a pathway by which immune cells prevent the lungs' protective barrier from healing after viral infections like COVID-19. The findings, published in Nature may lead to new therapeutic treatment options.
The COVID-19 pandemic revealed how viral infections can cause long-lasting effects – a condition called long COVID. Also known as post-acute sequelae of SARS-CoV-2, long COVID has left a devastating trail of people who continue to live with long-term debilitation after infection.
Investigators involved in a multicenter study co-led by Cedars-Sinai discovered a pathway by which immune cells prevent the lungs' protective barrier from healing after viral infections like COVID-19. The findings, published in Nature may lead to new therapeutic treatment options.
The COVID-19 pandemic revealed how viral infections can cause long-lasting effects – a condition called long COVID. Also known as post-acute sequelae of SARS-CoV-2, long COVID has left a devastating trail of people who continue to live with long-term debilitation after infection.
